| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/0961203313502863 |
| P698 | PubMed publication ID | 24098003 |
| P2093 | author name string | L J McCann | |
| M W Beresford | |||
| L Watson | |||
| T A Morgan | |||
| P2860 | cites work | Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity | Q22255577 |
| Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial | Q28304807 | ||
| A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: the university of Saskatchewan bone mineral accrual study | Q30774977 | ||
| Frequency of osteopenia in children and young adults with childhood-onset systemic lupus erythematosus | Q33218160 | ||
| Thrombocytopenia and thromboembolism in pediatric systemic lupus erythematosus | Q33357591 | ||
| Childhood systemic lupus erythematosus in Latin America. The GLADEL experience in 230 children. | Q33379920 | ||
| Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis | Q33397369 | ||
| Clinical significance of the antinuclear antibody test in selected children with idiopathic thrombocytopenic purpura | Q33500007 | ||
| Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. | Q33632260 | ||
| Osteoporosis in systemic lupus erythematosus: factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density | Q45013118 | ||
| Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort | Q45812853 | ||
| Crossing the transition chasm: experiences and recommendations for improving transitional care of young adults, parents and providers. | Q45827424 | ||
| Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome | Q46262236 | ||
| Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus | Q49154344 | ||
| Lupus nephritis is more severe in children and adolescents than in older adults. | Q51350730 | ||
| B cell depletion therapy for 19 patients with refractory systemic lupus erythematosus. | Q51726542 | ||
| Risk factors for amenorrhea in juvenile systemic lupus erythematosus (JSLE): a Brazilian multicentre cohort study. | Q51743744 | ||
| Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII) | Q33635924 | ||
| Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? | Q33723511 | ||
| Use of atorvastatin in systemic lupus erythematosus in children and adolescents | Q33818710 | ||
| Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus | Q33871944 | ||
| Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling | Q33999618 | ||
| Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus | Q34098573 | ||
| Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort | Q34161393 | ||
| Lupus headaches in childhood-onset systemic lupus erythematosus: relationship to disease activity as measured by the systemic lupus erythematosus disease activity index (SLEDAI) and disease damage | Q34226213 | ||
| Cyclophosphamide and cancer: golden anniversary | Q35005506 | ||
| Brief index of lupus damage: a patient-reported measure of damage in systemic lupus erythematosus | Q35146106 | ||
| The epidemiology of systemic lupus erythematosus | Q35148597 | ||
| Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management | Q35179614 | ||
| Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults | Q35548094 | ||
| Abdominal manifestations in childhood-onset systemic lupus erythematosus. | Q35638742 | ||
| Outcome in juvenile onset systemic lupus erythematosus | Q36225769 | ||
| Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus | Q36278355 | ||
| Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis | Q36302245 | ||
| Rituximab therapy for juvenile-onset systemic lupus erythematosus | Q36407310 | ||
| The management of pediatric systemic lupus erythematosus | Q36577380 | ||
| Therapy Insight: osteoporosis and osteonecrosis in systemic lupus erythematosus | Q36611056 | ||
| A comparison of autoimmune liver disease in juvenile and adult populations with systemic lupus erythematosus-a retrospective review of cases | Q36815441 | ||
| Gonadal functioning and preservation of reproductive fitness with juvenile systemic lupus erythematosus | Q36915646 | ||
| Systemic lupus erythematosus in the young: the importance of a transition clinic | Q36915658 | ||
| Therapy Insight: cardiovascular disease in pediatric systemic lupus erythematosus | Q37113440 | ||
| Childhood- and adult-onset lupus: an update of similarities and differences. | Q37754678 | ||
| Prevalence and burden of pediatric-onset systemic lupus erythematosus | Q37777642 | ||
| Updating on the pathogenesis of systemic lupus erythematosus | Q37791687 | ||
| Pediatric SLE--towards a comprehensive management plan | Q37850999 | ||
| The role of antimalarial agents in the treatment of SLE and lupus nephritis | Q37947108 | ||
| Not all hemophagocytes are created equally: appreciating the heterogeneity of the hemophagocytic syndromes | Q37956870 | ||
| Hormone replacement and contraceptive therapy in autoimmune diseases | Q37977272 | ||
| Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus | Q40940930 | ||
| Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect. | Q41929433 | ||
| Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus | Q41942520 | ||
| Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus | Q41977234 | ||
| Mycophenolate mofetil treatment in children and adolescents with lupus | Q42920250 | ||
| Ethnic differences in pediatric systemic lupus erythematosus | Q43796417 | ||
| Gonadal function in adolescents and young women with juvenile systemic lupus erythematosus. | Q44114229 | ||
| A longitudinal PRINTO study on growth and puberty in juvenile systemic lupus erythematosus | Q44492317 | ||
| P433 | issue | 12 | |
| P921 | main subject | teenager | Q1492760 |
| P304 | page(s) | 1309-1319 | |
| P577 | publication date | 2013-10-01 | |
| P1433 | published in | Lupus | Q6704846 |
| P1476 | title | Children and adolescents with SLE: not just little adults. | |
| P478 | volume | 22 |
| Q38679869 | Assessment of condyle, masseter and temporal muscles volumes in patients with juvenile systemic lupus erythematosus: A cross-sectional study. |
| Q39151466 | Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus |
| Q86015625 | Clinical applications of the indirect immunofluorescence assay for detection of anticell membrane-associated DNA antibodies in juvenile systemic lupus erythematosus |
| Q91915703 | Combination of tacrolimus and mycophenolate mofetil in persistent proteinuria due to refractory childhood lupus nephritis |
| Q33431990 | Differences in disease phenotype and severity in SLE across age groups |
| Q33437203 | Evaluating Anti-SmD1-amino-acid 83-119 Peptide Reactivity in Children with Systemic Lupus Erythematosus and Other Immunological Diseases |
| Q38865389 | Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis |
| Q48654210 | Inter-observer variability of the histological classification of lupus glomerulonephritis in children |
| Q39282087 | Lupus Means Sacrifices: Perspectives of Adolescents and Young Adults With Systemic Lupus Erythematosus. |
| Q38605850 | Lupus nephritis flare in young patients: relapse or nonadherence to treatment? |
| Q26768534 | Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway |
| Q91915080 | The impact of antiphospholipid antibodies in children with lupus nephritis |
| Q51121176 | The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE. |
Search more.